Entertainment Kolon TissueGene’s TG-C Fails Phase 3 Trial Key Metrics Amid Data Discrepancies by Lila Roberts - Entertainment Editor July 21, 2026 by Lila Roberts - Entertainment Editor July 21, 2026 Kolon TissueGene’s TG-C gene therapy failed to meet its primary endpoint in a U.S. Phase 3 clinical trial for osteoarthritis, according to company disclosures and regulatory filings. The result triggers … 0 FacebookTwitterPinterestEmail